Conversely, in colorectal cancer, GBP1 suppresses tumor growth, reducing proliferation and improving overall survival, possibly by enhancing immune recognition of tumor cells—a role tied to its predominant expression in gastrointestinal tissues and interferon-driven immune activation [23]. Here, GBP1 is linked to colorectal cancer.